Study to evaluate the efficacy of KVGAPs MEHACARE CAPSULE in Type II Diabetes Mellitus

A SINGLE ARM OPEN LABEL NON-RANDOMISED CLINICAL TRIAL TO EVALUATE THE EFFICACY OF KVGAP S MEHACARE CAPSULE IN MADHUMEHA (TYPE II DIABETES MELLITUS) - NIL

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/07/091804

Enrollment

Registered

2025-07-27

Start date

Unknown

Completion date

Unknown

Last updated

2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E119- Type 2 diabetes mellitus without complications

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1) Only uncomplicated cases of type-2 DM with FBS more than 126 mg/dl and less than 200 mg/dl. 2) With at least one of the following symptoms: Polyphagia, Polydypsia, Polyuria, Nocturnal micturition, Exhaustion/ Fatigue, Bodyache, Giddiness, Polyneuritis

Exclusion criteria

Exclusion criteria: 1) Patients presenting with complications like severe renal disease, ischemic heart disease, severe hypertension etc. 2) Patients with type-1 DM 3) Patients outside the age group of 30-65 years

Design outcomes

Primary

Measure	Time frame
Polyphagia, Polydypsia, Polyuria, Nocturnal micturition, Exhaustion/ Fatigue, Bodyache, Giddiness, PolyneuritisTimepoint: Baseline, After 15 days, After 30 Days, After 45 Days, After 60 days	—

Secondary

Measure	Time frame
NILTimepoint: NIL	—

Countries

India

Contacts

Public ContactDr Gopalakrishna N Nayak

KVG Ayurveda Medical College and Hospital

nayak.gkn@gmail.com9743643976

Outcome results